Jablonka Alexandra, Happle Christine, Wetzke Martin, Dopfer Christian, Merkesdal Sonja, Schmidt Reinhold E, Behrens Georg M N, Solbach Philipp
Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
German Center for Infection Research (DZIF), PARTNER Site Hannover-Braunschweig, Hannover, Germany.
Infect Dis Ther. 2017 Dec;6(4):487-496. doi: 10.1007/s40121-017-0169-7. Epub 2017 Sep 5.
The current extent of migration to the European continent is associated with exceptional humanitarian challenges. In 2015, Western Europe faced an enormous immigration of refugees with largely unknown protection status against communicable diseases. To adapt vaccination strategies, we aimed at assessing seroprevalences against three of the most relevant vaccine preventable diseases (VPD) in a large representative cohort.
IgG seroprevalences for rubella, varicella (n = 554) and measles (n = 552) were analyzed in inhabitants of a Northern German refugee camp in the summer of 2015.
Of the refugees, 77.9% were male (mean age 27.4 years for male and 26.8 years for female migrants). Most refugees came from the Eastern Mediterranean region (83.4%), followed by immigrants from Eastern Europe (7.4%), Africa (4.6%), or other regions (4.5%). The vast majority of migrants were protected against the three VPD: overall IgG seropositivity was 88.5% for measles, 77.9% for rubella and 95.9% for varicella. However, seroprevalences showed age- and origin-dependent differences. Varicella immunity, for example, was lowest in the youngest age group of both genders (10.1% of male/4.5% of female seronegative refugees <18 years vs. 100% seropositivity in men and women >49 years of age), and Sudanese migrants displayed particularly low rates of protection against varicella.
In accordance with previous studies, our analyses show an overall satisfactory seropositivity against measles, rubella, and varicella in refugees entering Europe during the current exodus. However, this rate is not sufficient for preventing transmission. For example, the rate of 12.9-17.9% female refugees at reproductive age unprotected against measles and the low protection levels against varicella in minors observed in our cohort emphasizes the need for stringent vaccination strategies in refugees coming to Europe during the current crisis.
目前向欧洲大陆的移民规模带来了特殊的人道主义挑战。2015年,西欧面临着大量难民涌入的情况,这些难民的传染病防护状况大多不明。为调整疫苗接种策略,我们旨在评估一个大型代表性队列中针对三种最相关的疫苗可预防疾病(VPD)的血清流行率。
2015年夏季,对德国北部一个难民营的居民进行了风疹、水痘(n = 554)和麻疹(n = 552)的IgG血清流行率分析。
难民中77.9%为男性(男性平均年龄27.4岁,女性移民平均年龄26.8岁)。大多数难民来自东地中海地区(83.4%),其次是来自东欧的移民(7.4%)、非洲的移民(4.6%)或其他地区的移民(4.5%)。绝大多数移民对三种VPD具有免疫力:麻疹的总体IgG血清阳性率为88.5%,风疹为77.9%,水痘为95.9%。然而,血清流行率存在年龄和来源相关的差异。例如,水痘免疫力在两个性别的最年轻年龄组中最低(18岁以下男性/女性血清阴性难民中,男性为10.1%/女性为4.5%,而49岁以上男性和女性的血清阳性率为100%),苏丹移民对水痘的防护率特别低。
与先前的研究一致,我们的分析表明,在当前难民潮期间进入欧洲的难民中,针对麻疹、风疹和水痘的总体血清阳性率令人满意。然而,这一比例不足以预防传播。例如,我们队列中12.9 - 17.9%的育龄期女性难民对麻疹无免疫力,以及未成年人对水痘的低防护水平,强调了在当前危机期间对进入欧洲的难民实施严格疫苗接种策略的必要性。